2021 Q4 Form 10-K Financial Statement
#000149315222008324 Filed on March 31, 2022
Income Statement
| Concept | 2021 Q4 | 2021 |
|---|---|---|
| Revenue | $50.00K | $135.0K |
| YoY Change | 19.05% | -17.18% |
| Cost Of Revenue | $176.0K | $850.0K |
| YoY Change | -11.11% | 5.46% |
| Gross Profit | -$126.0K | -$715.0K |
| YoY Change | -19.23% | 11.2% |
| Gross Profit Margin | -252.0% | -529.63% |
| Selling, General & Admin | $2.617M | $8.672M |
| YoY Change | 1.28% | 0.21% |
| % of Gross Profit | ||
| Research & Development | $2.923M | $7.672M |
| YoY Change | 34.13% | |
| % of Gross Profit | ||
| Depreciation & Amortization | $194.0K | $775.0K |
| YoY Change | 1.04% | 5.73% |
| % of Gross Profit | ||
| Operating Expenses | $5.540M | $16.34M |
| YoY Change | 14.02% | 13.71% |
| Operating Profit | -$5.666M | -$17.06M |
| YoY Change | 12.98% | 13.6% |
| Interest Expense | -$301.0K | -$268.0K |
| YoY Change | -1012.12% | -40.84% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $123.0K | $145.0K |
| YoY Change | -4200.0% | -217.89% |
| Pretax Income | -$5.846M | -$19.13M |
| YoY Change | 48.6% | 32.83% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$5.846M | -$19.13M |
| YoY Change | 48.6% | 32.83% |
| Net Earnings / Revenue | -11692.0% | -14168.15% |
| Basic Earnings Per Share | -$0.40 | |
| Diluted Earnings Per Share | -$122.1K | -$404.0K |
| COMMON SHARES | ||
| Basic Shares Outstanding | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 Q4 | 2021 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $48.27M | $48.27M |
| YoY Change | 23.76% | 23.76% |
| Cash & Equivalents | $32.09M | $32.09M |
| Short-Term Investments | $16.18M | $16.18M |
| Other Short-Term Assets | $304.0K | $304.0K |
| YoY Change | 65.22% | 65.22% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $1.641M | |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $50.21M | $50.21M |
| YoY Change | 24.57% | 24.57% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $4.047M | $4.196M |
| YoY Change | -39.16% | -36.92% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% |
| Other Assets | $1.316M | $1.316M |
| YoY Change | 75.94% | 75.94% |
| Total Long-Term Assets | $7.486M | $7.486M |
| YoY Change | -69.16% | -69.16% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $50.21M | $50.21M |
| Total Long-Term Assets | $7.486M | $7.486M |
| Total Assets | $57.70M | $57.70M |
| YoY Change | -10.66% | -10.66% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $198.0K | $198.0K |
| YoY Change | -48.3% | -48.3% |
| Accrued Expenses | $438.0K | $475.0K |
| YoY Change | -10.43% | -2.86% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $0.00 | |
| YoY Change | -100.0% | |
| Total Short-Term Liabilities | $673.0K | $673.0K |
| YoY Change | -38.93% | -38.93% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | |
| YoY Change | -100.0% | |
| Other Long-Term Liabilities | $147.0K | $147.0K |
| YoY Change | -52.88% | -52.88% |
| Total Long-Term Liabilities | $0.00 | $147.0K |
| YoY Change | -100.0% | -93.28% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $673.0K | $673.0K |
| Total Long-Term Liabilities | $0.00 | $147.0K |
| Total Liabilities | $673.0K | $820.0K |
| YoY Change | -79.54% | -75.08% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$361.1M | |
| YoY Change | ||
| Common Stock | $417.3M | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $56.88M | $56.88M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $57.70M | $57.70M |
| YoY Change | -10.66% | -10.66% |
Cashflow Statement
| Concept | 2021 Q4 | 2021 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$5.846M | -$19.13M |
| YoY Change | 48.6% | 32.83% |
| Depreciation, Depletion And Amortization | $194.0K | $775.0K |
| YoY Change | 1.04% | 5.73% |
| Cash From Operating Activities | -$5.745M | -$13.97M |
| YoY Change | 101.3% | 34.69% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$155.0K | -$633.0K |
| YoY Change | -45.61% | 6.39% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $519.0K | $2.000K |
| YoY Change | 403.88% | -100.02% |
| Cash From Investing Activities | $364.0K | -$631.0K |
| YoY Change | -300.0% | -93.11% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | $122.0K | |
| YoY Change | ||
| Cash From Financing Activities | 125.0K | 8.188M |
| YoY Change | -95.89% | -85.52% |
| NET CHANGE | ||
| Cash From Operating Activities | -5.745M | -13.97M |
| Cash From Investing Activities | 364.0K | -631.0K |
| Cash From Financing Activities | 125.0K | 8.188M |
| Net Change In Cash | -5.256M | -6.408M |
| YoY Change | -105220.0% | -117.3% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$5.745M | -$13.97M |
| Capital Expenditures | -$155.0K | -$633.0K |
| Free Cash Flow | -$5.590M | -$13.33M |
| YoY Change | 117.59% | 36.42% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
USD | |
| CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
USD | |
| CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
USD | |
| CY2020 | AIM |
Reclassification Adjustment For Realized Investment Lost
ReclassificationAdjustmentForRealizedInvestmentLost
|
USD | |
| CY2021 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
USD | |
| CY2021 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
USD | |
| CY2020 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
| CY2021 | us-gaap |
Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
|
USD | |
| CY2021 | AIM |
Warrant Modification
WarrantModification
|
USD | |
| CY2021 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
USD | |
| CY2020 | us-gaap |
Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
|
USD | |
| CY2021 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
USD | |
| CY2020 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | |
| CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
USD | |
| CY2021 | us-gaap |
Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
|
USD | |
| CY2020Q4 | AIM |
Debt Securities Available For Sale Continuous Unrealized Gain Loss Position Less Than12
DebtSecuritiesAvailableForSaleContinuousUnrealizedGainLossPositionLessThan12
|
USD | |
| CY2020Q4 | AIM |
Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
|
USD | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
| CY2021Q4 | AIM |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
USD | |
| CY2021Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
|
USD | |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2021Q4 | us-gaap |
Land And Land Improvements
LandAndLandImprovements
|
3900000 | USD |
| CY2021 | us-gaap |
Gain Loss On Fair Value Hedge Ineffectiveness Net
GainLossOnFairValueHedgeIneffectivenessNet
|
1800000 | USD |
